Know what your products do to women's hormones. Then fix it before regulators make you.
Upload your formulations. In seconds, see which ingredients disrupt estrogen, testosterone, thyroid, and insulin pathways - scored against 9 hormonal conditions with PubMed-cited evidence. Get exact swap recommendations that maintain efficacy. See which ingredients face regulatory restriction in 18-36 months. Stop paying consultants $500/hr for what our engine does instantly.
Upload formulations. Get intelligence. Reformulate faster.
Compliance tools flag problems. We solve them - with specific swap recommendations, predictive risk, and the deepest hormonal impact database in the industry.
Upload Your Formulations
Share your product catalogue in any format - spreadsheet, PDF, or direct from your PIM. Our engine parses every ingredient, maps it against 2,800+ hormonal interactions, and scores your entire portfolio in seconds.
Get Reformulation Intelligence
Every flagged ingredient comes with exact swap recommendations - what to replace it with, the efficacy trade-off, the cost delta, and the evidence. Not just 'this is bad.' Specifically: 'replace methylparaben with phenoxyethanol, same preservative function, no estrogenic activity, here are the studies.'
See What's Coming Next
Every ingredient gets a predictive regulatory risk score based on emerging science, ECHA evaluations in progress, and EU/UK/US regulatory signals. Know which ingredients in your portfolio face 70%+ restriction probability within 24 months. Reformulate now, not when the deadline hits.
What you get that compliance tools can't give you
Regulations tell you what was dangerous. We tell you what's next.
The science of endocrine disruption is a decade ahead of regulation. Brands that only react to today's rules will reformulate under pressure. Brands with predictive intelligence reformulate on their terms.
Deadlines Are Months Away
EU PFAS ban in cosmetics - Oct 2026 deadline
EU Commission56 new fragrance allergen restrictions - Jul 2026
EU Cosmetic RegBPA ban in food-contact materials - Jul 2026
EU Commission137 substances under ECHA endocrine disruptor assessment
ECHA15-40% of large brand SKUs face reformulation pressure
Value GeneScience Is 10 Years Ahead of Regulation
BPA flagged in research in the 1990s - EU ban took until 2025
Regulatory lagPhthalates flagged in the 2000s - restrictions still ongoing
Regulatory lagHundreds of ingredients in the gap: flagged by science, not yet restricted
PubMedCompliance tools only see regulations. They miss the 10-year gap entirely.
Market gapBrands that reformulate ahead of regulation save millions in recalls
Industry"Hormone-Safe" Is the New Premium
Clean beauty market $10.5B → $29B by 2033 (13.5% CAGR)
SNS InsiderConsumers pay 40% premium for hormone-safe products
Industry dataIndie beauty growing 22.3% YoY, outpacing conglomerates 4:1
NielsenIQ85% of UK women report hormonal health challenges
LuminaNo platform tells brands how to reformulate for hormonal safety
Market gapReplace $500/hr consultants with an engine that learns.
Reformulation consultants give you a PDF and move on. Our platform monitors your entire portfolio continuously, alerts you when new science emerges, and gets smarter with every formulation it analyses.
Growth
Indie and mid-market brands, up to 100 SKUs
- Full portfolio hormonal impact scoring
- Condition-specific grades across 9 conditions
- Ingredient-level reformulation swap recommendations
- PubMed-cited evidence per flagged ingredient
- Quarterly predictive regulatory risk report
- Category benchmarking dashboard
Enterprise
Large brands, CPG companies, contract manufacturers
- Everything in Growth, plus:
- Unlimited SKUs across all product lines
- Continuous predictive regulatory risk modelling (18-36 months)
- Reformulation cost-impact analysis with supplier data
- Real-time monitoring alerts for emerging science
- Competitive portfolio benchmarking
- Dedicated account team and API access
- Custom reporting for R&D and regulatory teams
Why not just use a compliance tool?
Compliance tools check your formulas against today's regulations. They tell you if you pass. They don't tell you what to reformulate with, what regulators will restrict next, or how specific ingredients affect women with PCOS, endometriosis, or thyroid conditions. That's the difference between avoiding a fine and leading a $29B market.
What makes your scoring different?
Generic safety databases flag ingredients for broad toxicity. Our engine maps ingredients to specific hormonal pathways - estrogenic activity, androgenic disruption, thyroid interference, insulin signalling - scored against 9 conditions. A paraben in a leave-on cream is weighted differently than in a rinse-off product. No other platform has this depth.
See how your formulations score. In 20 minutes.
Send us 3 product formulations. On the call, we'll score them live - hormonal impact per ingredient, flagged chemicals, swap recommendations, and predictive regulatory risk. You'll know exactly where your portfolio stands.
20-minute call · We score your own products live · No commitment